BIOMAT Database Logo BIOMAT Database Logo

Cerebrospinal fluid oligocional proteins in amyotrophic lateral sclerosis. 1979

B T Adornato, and S A Houff, and W K Engel, and J L Sever

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000690 Amyotrophic Lateral Sclerosis A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94) ALS - Amyotrophic Lateral Sclerosis,Lou Gehrig Disease,Motor Neuron Disease, Amyotrophic Lateral Sclerosis,Amyotrophic Lateral Sclerosis With Dementia,Amyotrophic Lateral Sclerosis, Guam Form,Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam,Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1,Charcot Disease,Dementia With Amyotrophic Lateral Sclerosis,Gehrig's Disease,Guam Disease,Guam Form of Amyotrophic Lateral Sclerosis,Lou Gehrig's Disease,Lou-Gehrigs Disease,ALS Amyotrophic Lateral Sclerosis,Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1,Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam,Disease, Guam,Disease, Lou-Gehrigs,Gehrig Disease,Gehrigs Disease,Sclerosis, Amyotrophic Lateral

Related Publications

B T Adornato, and S A Houff, and W K Engel, and J L Sever
[Cerebrospinal fluid proteins in the course of amyotrophic lateral sclerosis].
November 1971, Revue neurologique,
B T Adornato, and S A Houff, and W K Engel, and J L Sever
Cerebrospinal fluid filtration in amyotrophic lateral sclerosis.
September 1999, European journal of neurology,
B T Adornato, and S A Houff, and W K Engel, and J L Sever
[Cerebrospinal fluid cytotoxicity in lateral amyotrophic sclerosis].
January 2010, Neurologia (Barcelona, Spain),
B T Adornato, and S A Houff, and W K Engel, and J L Sever
Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.
February 2018, Annals of neurology,
B T Adornato, and S A Houff, and W K Engel, and J L Sever
Cerebrospinal fluid amino acids in amyotrophic lateral sclerosis.
April 1992, Annals of neurology,
B T Adornato, and S A Houff, and W K Engel, and J L Sever
Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
April 2007, Neuroscience letters,
B T Adornato, and S A Houff, and W K Engel, and J L Sever
Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis.
January 1984, Journal of neurology,
B T Adornato, and S A Houff, and W K Engel, and J L Sever
Decreased cerebrospinal-fluid superoxide dismutase in amyotrophic lateral sclerosis.
October 1993, Lancet (London, England),
B T Adornato, and S A Houff, and W K Engel, and J L Sever
Amyotrophic lateral sclerosis: interleukin-6 levels in cerebrospinal fluid.
August 1992, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
B T Adornato, and S A Houff, and W K Engel, and J L Sever
Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis.
June 2016, Experimental and therapeutic medicine,
Copied contents to your clipboard!